Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor.
Barrow, AD; Edeling, MA; Trifonov, V; Luo, J; Goyal, P; Bohl, B; Bando, JK; Kim, AH; Walker, J; Andahazy, M; Bugatti, M; Melocchi, L; Vermi, W; Fremont, DH; Cox, S; Cella, M; Schmedt, C; Colonna, M
Cell
172
534-548.e19
2018
Abstract anzeigen
Many tumors produce platelet-derived growth factor (PDGF)-DD, which promotes cellular proliferation, epithelial-mesenchymal transition, stromal reaction, and angiogenesis through autocrine and paracrine PDGFRβ signaling. By screening a secretome library, we found that the human immunoreceptor NKp44, encoded by NCR2 and expressed on natural killer (NK) cells and innate lymphoid cells, recognizes PDGF-DD. PDGF-DD engagement of NKp44 triggered NK cell secretion of interferon gamma (IFN)-γ and tumor necrosis factor alpha (TNF-α) that induced tumor cell growth arrest. A distinctive transcriptional signature of PDGF-DD-induced cytokines and the downregulation of tumor cell-cycle genes correlated with NCR2 expression and greater survival in glioblastoma. NKp44 expression in mouse NK cells controlled the dissemination of tumors expressing PDGF-DD more effectively than control mice, an effect enhanced by blockade of the inhibitory receptor CD96 or CpG-oligonucleotide treatment. Thus, while cancer cell production of PDGF-DD supports tumor growth and stromal reaction, it concomitantly activates innate immune responses to tumor expansion. | 29136505
 |
